SNDL Stock Forecast: Sundial Growers closes lower after early morning surge
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get all exclusive analysis, access our analysis and get Gold and signals alerts
Elevate your trading Journey.
UPGRADE- NASDAQ:SNDL fell by 0.34% during Friday’s trading session.
- Sundial’s acquisitions are leading to record sales as the company tries to rebuild.
- Cannabis stocks declined on Friday despite recent Senate buzz.
NASDAQ:SNDL failed to keep its momentum going from Thursday, although the stock did post a positive week overall, climbing higher by about 5.0%. On Friday, shares of SNDL dipped lower by 0.34% and closed the trading week at a price of $2.95. Stocks had their worst trading day in months as Fed Chairman Jerome Powell gave his speech from Jackson Hole on Friday morning. Powell provided a hawkish outlook and stated that there could be some pain ahead as the Fed continues to fight inflation. Overall, the Dow Jones tumbled by 1,008 basis points, the S&P 500 dropped by 3.37%, and the NASDAQ plummeted by 3.94% during the session.
Stay up to speed with hot stocks' news!
Is Sundial turning a corner? In the second quarter it turned in a record sales report and a lot of it was due to it being the first quarter where Alcanna’s liquor sales were included in the numbers. It’s a good sign that Sundial’s strategic acquisitions are making an impact on its sales figures, but so far the stock has not followed suit. In fact, the reverse split that Sundial was forced to undergo just to remain listed on the NASDAQ is a sure sign that the company is not doing as well as they would lead us to believe.
SNDL stock price
Despite Thursday’s buzz about potential industry reform at the Senate level, cannabis stocks erased those gains on Friday. Led lower by industry leaders like Tilray (NASDAQ:TLRY) which fell by 7.04%, Aurora Cannabis (NASDAQ:ACB) which dropped by 9.41%, and Canopy Growth (NASDAQ:CGC) which lost 9.22% to close the week.
Like this article? Help us with some feedback by answering this survey:
- NASDAQ:SNDL fell by 0.34% during Friday’s trading session.
- Sundial’s acquisitions are leading to record sales as the company tries to rebuild.
- Cannabis stocks declined on Friday despite recent Senate buzz.
NASDAQ:SNDL failed to keep its momentum going from Thursday, although the stock did post a positive week overall, climbing higher by about 5.0%. On Friday, shares of SNDL dipped lower by 0.34% and closed the trading week at a price of $2.95. Stocks had their worst trading day in months as Fed Chairman Jerome Powell gave his speech from Jackson Hole on Friday morning. Powell provided a hawkish outlook and stated that there could be some pain ahead as the Fed continues to fight inflation. Overall, the Dow Jones tumbled by 1,008 basis points, the S&P 500 dropped by 3.37%, and the NASDAQ plummeted by 3.94% during the session.
Stay up to speed with hot stocks' news!
Is Sundial turning a corner? In the second quarter it turned in a record sales report and a lot of it was due to it being the first quarter where Alcanna’s liquor sales were included in the numbers. It’s a good sign that Sundial’s strategic acquisitions are making an impact on its sales figures, but so far the stock has not followed suit. In fact, the reverse split that Sundial was forced to undergo just to remain listed on the NASDAQ is a sure sign that the company is not doing as well as they would lead us to believe.
SNDL stock price
Despite Thursday’s buzz about potential industry reform at the Senate level, cannabis stocks erased those gains on Friday. Led lower by industry leaders like Tilray (NASDAQ:TLRY) which fell by 7.04%, Aurora Cannabis (NASDAQ:ACB) which dropped by 9.41%, and Canopy Growth (NASDAQ:CGC) which lost 9.22% to close the week.
Like this article? Help us with some feedback by answering this survey:
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.